Prescription weight loss medications: GLP-1 medications like Mounjaro have extensive clinical evidence showing 15-25% weight loss
Originally, these weekly injections were designed to treat patients with type 2 diabetes by stimulating insulin production and regulating blood sugar levels
If this trial is successful, we will have the evidence necessary to show the medical community that obesity is a reversible risk factor for atherosclerotic cardiovascular disease and other outcomes, he says
That's the gap these platforms exist to close - and in a category where many patients previously faced months-long waits for in-person weight management appointments, the difference is real
This place is all about supporting people on their journey to losing weight, making sure they reach their targets with the help of skilled professionals
The review will include an assessment of the affordability of GLP-1, said the health departments deputy director-general for primary healthcare, Jeanette Hunter
